Veronica Sanchez Bulis

LYEL

Veronica Sanchez Bulis serves as VP, Corporate Controller at Lyell Immunopharma, Inc. (LYEL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$83.9K

Net Position

Net Seller

$83.9K

Companies Traded

LYEL

Active Period

Nov 2025 – Feb 2026

3 total trades

Most Recent

Sell LYEL

Feb 10, 2026 · $5.9K

Veronica Sanchez Bulis's Insider Trading at Lyell Immunopharma, Inc. (LYEL)

Buys

0 · $0.00

Sells

3 · $83.9K

Total Shares Bought

Total Shares Sold

2,565

LYEL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Feb 10, 2026	Sell	254	$23.12	$5.9K
Dec 24, 2025	Sell	2,072	$35.80	$74.2K
Nov 10, 2025	Sell	239	$16.10	$3.8K

Related Insiders

David Shook

officer: Chief Medical Officer

LYELSell · Jun 11, 2026

ARCH Venture Fund XIII, L.P.

10 percent owner

LYELBuy · Mar 9, 2026

ARCH Venture Partners IX, LLC

10 percent owner

LYELBuy · Mar 9, 2026

Gary K. Lee

Chief Scientific Officer

LYELSell · Feb 11, 2026

Stephen J. Hill

Chief Operating Officer

LYELSell · Feb 11, 2026

Lynn Seely

President and CEO

LYELSell · Feb 11, 2026

Charles W. Newton

Chief Financial Officer

LYELSell · Aug 20, 2025

Explore More Insider Trading Data

LYEL Insider Trading Activity

View all insider trades at Lyell Immunopharma, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity